These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28585582)

  • 1. Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan.
    Kanwal S; Akhtar AM; Ahmed A
    J Pak Med Assoc; 2017 Jun; 67(6):858-862. PubMed ID: 28585582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan.
    Khan I; Ahmad N; Khan S; Muhammad S; Ahmad Khan S; Ahmad I; Khan A; Gulalai ; Atif M
    J Infect Public Health; 2019; 12(6):809-815. PubMed ID: 31056438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan.
    Akhtar AM; Arif MA; Kanwal S; Majeed S
    J Pak Med Assoc; 2016 Aug; 66(8):989-93. PubMed ID: 27524534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan.
    Massud A; Khan AH; Syed Sulaiman SA; Ahmad N; Shafqat M; Ming LC
    PLoS One; 2023; 18(8):e0287966. PubMed ID: 37561810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.
    Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC
    Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study.
    Javaid A; Ullah I; Masud H; Basit A; Ahmad W; Butt ZA; Qasim M
    Clin Microbiol Infect; 2018 Jun; 24(6):612-617. PubMed ID: 28970158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference?
    Balabanova Y; Ignatyeva O; Fiebig L; Riekstina V; Danilovits M; Jaama K; Davidaviciene E; Radiulyte B; Popa CM; Nikolayevskyy V; Drobniewski F
    Thorax; 2016 Sep; 71(9):854-61. PubMed ID: 27012887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.
    Dheda K; Shean K; Zumla A; Badri M; Streicher EM; Page-Shipp L; Willcox P; John MA; Reubenson G; Govindasamy D; Wong M; Padanilam X; Dziwiecki A; van Helden PD; Siwendu S; Jarand J; Menezes CN; Burns A; Victor T; Warren R; Grobusch MP; van der Walt M; Kvasnovsky C
    Lancet; 2010 May; 375(9728):1798-807. PubMed ID: 20488525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Analysis of Risk Factors for Mortality in a Cohort of Patients with Tuberculosis.
    Xie Y; Han J; Yu W; Wu J; Li X; Chen H
    Can Respir J; 2020; 2020():1654653. PubMed ID: 32963642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment of tuberculosis - update 2011].
    von Groote-Bidlingmaier F; Diacon AH
    Ther Umsch; 2011 Jul; 68(7):395-401. PubMed ID: 21728158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes in extensively resistant tuberculosis.
    Chan ED; Strand MJ; Iseman MD
    N Engl J Med; 2008 Aug; 359(6):657-9. PubMed ID: 18687654
    [No Abstract]   [Full Text] [Related]  

  • 15. Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan.
    Ullah I; Javaid A; Tahir Z; Ullah O; Shah AA; Hasan F; Ayub N
    PLoS One; 2016; 11(1):e0147529. PubMed ID: 26809127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study.
    Schnippel K; Ndjeka N; Maartens G; Meintjes G; Master I; Ismail N; Hughes J; Ferreira H; Padanilam X; Romero R; Te Riele J; Conradie F
    Lancet Respir Med; 2018 Sep; 6(9):699-706. PubMed ID: 30001994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for high death and loss-to-follow-up rates among patients with multidrug-resistant tuberculosis at a programmatic management unit.
    Javaid A; Shaheen Z; Shafqat M; Khan AH; Ahmad N
    Am J Infect Control; 2017 Feb; 45(2):190-193. PubMed ID: 27769706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Javaid A; Hasan R; Zafar A; Chaudry MA; Qayyum S; Qadeer E; Shaheen Z; Agha N; Rizvi N; Afridi MZ; Chima MK; Khan AR; Ghafoor A; Khan S; Awan SR; Akhtar S; Choudry K; Iqbal ZH; Ansarie M; Ahmad N
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):303-308. PubMed ID: 28225340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.